Alnylam Pharmaceuticals
ALNY
#439
Rank
NZ$92.54 B
Marketcap
NZ$700.52
Share price
1.87%
Change (1 day)
63.42%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Stock price history for Alnylam Pharmaceuticals (ALNY)

Highest end of day price: NZ$843.97 NZD on 2025-10-20

Lowest end of day price: NZ$6.79 NZD on 2004-08-16

Stock price history of Alnylam Pharmaceuticals from 2004 to 2025

Annual Stock Price Performance

Year Performance
2025 74.53%
2024 20.72%
2023-18.06%
2022 36.65%
2021 32.38%
2020 12.41%
2019 58.29%
2018-44.70%
2017 228.80%
2016-59.75%
2015-3.71%
2014 51.89%
2013 235.42%
2012 110.74%
2011-18.58%
2010-45.64%
2009-29.94%
2008-14.49%
2007 34.82%
2006 65.12%
2005 75.73%
2004 6.71%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
NZ$118.55 1.23%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1,339 1.48%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$36.48 0.90%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.29 1.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$14.02 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$235.16 0.60%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$82.52-0.31%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$53.62 2.83%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel